Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • O vs MRNA✓SelectedUSD · MRNAO vs MRNA performance historyLatest closeAs of-0.87%11/17
Stock and ETF performance explorer

O vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.7%
MRNA return
-11.9%
Excess return
+16.6%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.9%-3.9%+3.1%-0.8%
7D-2.5%-17.6%+15.0%-2.1%
30D+4.0%-5.1%+9.1%+4.0%
3M-5.7%+220.8%-226.5%-10.1%
6M-2.4%+321.7%-324.1%-8.6%
YTD+7.6%+601.3%-593.6%-2.7%
1Y+7.4%+735.2%-727.8%-4.1%
3Y+29.5%+170.5%-141.1%+20.6%
5Y+4.7%-14.6%+19.3%+1.4%
All+4.7%-11.9%+16.6%+1.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling